April 2, 2026
Monaco, April 2, 2026 — Rapalogix Health, a biotechnology company advancing a science-first approach to cellular longevity and skin health, announced today that it has received the Catalyst Award at the Aesthetic & Anti-Aging Medicine World Congress (AMWC) in Monaco.
The AMWC is one of the most competitive and globally recognized forums for innovation in medical aesthetics and anti-aging medicine, drawing leading dermatologists, plastic surgeons, and longevity scientists from around the world. The Catalyst Award for the Most Disruptive Innovation recognizes emerging companies demonstrating exceptional promise across four core criteria: Innovation and/or Distinctiveness, Efficacy, Safety, and Market Need, as evaluated by a panel of 77 jurors and determined through a combination of jury and attendee votes. Rapalogix Health was selected from a strong international field of competitors.
Rapalogix Health was recognized for RLX-201, its proprietary pro-longevity molecule, and Re-Q Pro-Longevity Face Serum, the first product from its professional skincare brand, Re-Q Health. RLX-201 is a patented pro-longevity molecule designed to restore youthful cellular function through modulation of mTORC1 activity in the skin.
"Each recognition we receive adds to a growing sense that the field is ready for what we are building,” said Rahul Mehta, PhD, CEO and Co-Founder of Rapalogix Health. "We are honored to be recognized at AMWC Monaco, one of the world's most respected stages for aesthetic and regenerative innovation, and feel energized in our mission to translate that conviction into meaningful outcomes for patients and physicians."
The Catalyst Award marks Rapalogix Health's fourth major industry recognition in 2026, following the Judges' Choice Award at Octane's 7th Annual Aesthetics Tech Forum, Start-Up of the Year and Cellular Signaling & Advanced Longevity Mechanisms Awards at the INNOCOS Beauty, Tech & Longevity Summit in Silicon Valley, and First Place, Start-Up of the Year at the Innovation Tank by IMCAS World Congress in Paris.
Across all four recognitions, a consistent theme has emerged: strong validation of Rapalogix Health's scientific approach, clear differentiation in the market, and confidence in its path to commercialization. Rapalogix Health will continue advancing RLX-201 through clinical development and expanding collaborations with physicians and scientific partners globally.
About Rapalogix Health
Rapalogix Health is a New York-based biotechnology company pioneering the next evolution in skin health. We translate foundational insights in longevity science into transformative dermatological solutions. Grounded in a science-first approach, the company is developing an innovative pipeline of prescription therapeutics and professional skincare products. Re-Q Pro-Longevity Face Serum, the first product from Rapalogix's professional skincare brand, Re-Q Health, is now available at select dermatology practices in the United States. Re-Q Pro-Longevity Face Serum is powered by RLX-201, Rapalogix's proprietary pro-longevity molecule designed to reset and restore exhausted skin cells, extend their longevity, and deliver healthy and youthful skin over a lifetime.
For more information on Rapalogix Health, visit www.rapalogix.com or follow Rapalogix on LinkedIn and Instagram.
For more information on Re-Q Health, visit www.reqhealth.com or follow Re-Q Health on Instagram.
About the Aesthetic & Anti-Aging Medicine World Congress (AMWC)
The Aesthetic and Anti-Aging Medicine World Congress (AMWC) is the world's leading event for the continuing education of physicians and the fostering of meaningful professional connections in aesthetic and anti-aging medicine. Held annually in Monaco under the High Patronage of H.S.H. Prince Albert II, AMWC brings together more than 17,000 practitioners and over 350 exhibitors from across the globe. With 24 years of conference production, AMWC offers an unparalleled scientific program supervised by the Aesthetic Multispecialty Society (AMS) and presented by internationally recognized key opinion leaders across plastic surgery, aesthetic dermatology, and anti-aging medicine. For more information, visit www.amwc-conference.com.
